We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-2.78%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$447M
AUM Growth
-$13.3M
Cap. Flow
+$5.46M
Cap. Flow %
1.22%
Top 10 Hldgs %
59.92%
Holding
43
New
3
Increased
15
Reduced
12
Closed
6

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10M
2
MDT icon
Medtronic
MDT
+$8.56M
3
ZBH icon
Zimmer Biomet
ZBH
+$8.42M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$7.32M
5
BSX icon
Boston Scientific
BSX
+$5.59M

Top Sells

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$9.52M
2
AZN icon
AstraZeneca
AZN
+$8.23M
3
MRK icon
Merck
MRK
+$7.52M
4
BDX icon
Becton Dickinson
BDX
+$6.98M
5
PDCO
Patterson Companies, Inc.
PDCO
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$52.1M 11.66%
843,427
+161,889
+24% +$10M
MRK icon
2
Merck
MRK
$315B
$37.8M 8.45%
414,338
-84,803
-17% -$7.52M
INCY icon
3
Incyte
INCY
$23.4B
$34.9M 7.81%
459,429
+17,417
+4% +$1.32M
MDT icon
4
Medtronic
MDT
$106B
$26.1M 5.83%
290,521
+84,515
+41% +$8.56M
BMY icon
5
Bristol-Myers Squibb
BMY
$124B
$24M 5.37%
311,696
-21,862
-7% -$1.67M
CAH icon
6
Cardinal Health
CAH
$53.5B
$20.2M 4.51%
385,988
+8,718
+2% +$495K
BSX icon
7
Boston Scientific
BSX
$65.4B
$19.9M 4.44%
532,735
+137,400
+35% +$5.59M
BIIB icon
8
Biogen
BIIB
$30.4B
$18.9M 4.22%
92,497
+10,552
+13% +$2.16M
CI icon
9
Cigna
CI
$74.5B
$17.5M 3.91%
66,283
+7,913
+14% +$2.04M
ELV icon
10
Elevance Health
ELV
$80.9B
$16.6M 3.7%
34,300
+5,282
+18% +$2.61M
BRKR icon
11
Bruker
BRKR
$8.86B
$15.8M 3.53%
251,042
-910
-0.4% -$55.8K
CVS icon
12
CVS Health
CVS
$137B
$15.6M 3.49%
168,111
-30,762
-15% -$3M
CNC icon
13
Centene
CNC
$32.8B
$15.4M 3.44%
181,799
-12,865
-7% -$1.07M
ZBH icon
14
Zimmer Biomet
ZBH
$17.6B
$14.3M 3.19%
135,749
+70,948
+109% +$8.42M
NUVA
15
DELISTED
NuVasive, Inc.
NUVA
$12.2M 2.72%
247,502
-18,533
-7% -$994K
OGN icon
16
Organon & Co
OGN
$3.55B
$12M 2.69%
356,089
+16,351
+5% +$573K
QGEN icon
17
Qiagen
QGEN
$8.49B
$9.52M 2.13%
190,242
-16,500
-8% -$805K
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$123B
$9.43M 2.11%
33,474
+8,716
+35% +$2.33M
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
$8.99M 2.01%
+50,795
New +$7.32M
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.72M 1.95%
105,259
+25,500
+32% +$2.03M
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$35.7B
$6.25M 1.4%
42,844
-16,407
-28% -$2.33M
IONS icon
22
Ionis Pharmaceuticals
IONS
$8.99B
$6.13M 1.37%
165,439
-23,000
-12% -$867K
BIO icon
23
Bio-Rad Laboratories Class A
BIO
$8.15B
$5.83M 1.31%
11,785
-1,000
-8% -$521K
ABT icon
24
Abbott
ABT
$175B
$5.35M 1.2%
+49,205
New +$5.59M
PFE icon
25
Pfizer
PFE
$143B
$5.24M 1.17%
100,000
-29,738
-23% -$1.52M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2022 Portfolio in Review

As of Q2 2022, Sector Gamma AS held 43 positions worth $447M, down 2.9% from $460M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS's Q2 2022 filing shows 3 new, 15 increased, 12 reduced and 6 closed positions. Its largest new stake was Seagen Inc. Common Stock: 50,795 shares worth $8.99M. The largest sale was Elanco Animal Health, an estimated $9.52M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2022 buy was Seagen Inc. Common Stock: 50,795 shares worth $8.99M.
  • Sector Gamma AS added most to Gilead Sciences in Q2 2022, an estimated $10M increase.
  • Sector Gamma AS's biggest Q2 2022 reduction was Merck, cutting an estimated $7.52M.
  • Sector Gamma AS fully exited Elanco Animal Health in Q2 2022, selling an estimated $9.52M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $447M portfolio in Q2 2022.
  • Sector Gamma AS opened 3 new positions and closed 6 in Q2 2022.
  • Sector Gamma AS's portfolio value fell 2.9% quarter-over-quarter to $447M.

Based on Sector Gamma AS's 13F filing for Q2 2022, filed 5 Aug 2022.